Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by 4Justiceon Jul 28, 2021 12:56pm
75 Views
Post# 33617164

TOMMY THE DREAMER

TOMMY THE DREAMERWould you please tell me what justified this $10 target price ? It represents $ 300 millions market cap ! 

In 6 months may be Liminal will have a $70 millions income from the voucher but they will spend $5 millions a month to operate and the company has $45 millions of debt.

Right now they have no more then $ 20 millions of cash. Just enough to run 4 months.

Do your math my friend Liminal is in big trouble and the MN&A of Q2 2021 will show you the real financial situation.

In all figures you're out of money with out any recurent incomes. The voucher is not enough to justified $300 millions of value.

I think before Q2 result you're gona see $2. Just my tought !

<< Previous
Bullboard Posts
Next >>